3’‐Dehydroxypurpurogallin‐4‐Carboxamides as Influenza A Endonuclease Inhibitors: Synthesis, Structure‐Activity Relationship Analysis, and Structural Characterization of Protein Complex
ChemMedChem · 2025
DOI: 10.1002/cmdc.202400577 ↗At a glance
Journal article in ChemMedChem, 2025. Written by Michal Kráľ and 10 co-authors. Institution: Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo náměstí 542/2, Prague 6, 160 00, Czech Republic. Major MEDLINE topics: Antiviral Agents, Enzyme Inhibitors, Influenza A virus, Endonucleases. Cited 1 times so far (Crossref); 64 references. The full text is freely available (open access, CC BY 4.0). Funded by: European Union - Next Generation EU -, National Institute of Virology and Bacteriology, Academy of Sciences of the Czech Republic.
Abstract (original language)
The influenza RNA‐dependent RNA polymerase harbours an endonuclease subunit characterized by a catalytic site housing two divalent metal ions. By effectively chelating both Mg 2+ and Mn 2+ ions, a small‐molecule inhibitor with a metal‐binding pharmacophore can halt endonuclease activity. Herein, two 3’‐dehydroxypurpurogallin‐4‐carboxamide series, namely twelve C‐4’ unsubstituted and twelve C‐4’ phenyl substituted congeners were designed and prepared to be tested as inhibitors of the metal‐dependent viral enzyme. These inhibitors were accessed through the chemoenzymatic reaction of gallic acid with either pyrocatechol or phenylpyrocatechol moderated by laccase , followed by amidation. Experimental IC 50 values were determined using AlphaScreen technology, with the most potent inhibitors exhibiting IC 50 values around 0.35 μM. Using X‐ray crystallography, we analyzed structure of the endonuclease in complex with one potent 3’‐dehydroxypurpurogallin‐carboxamide at 2.0 Å resolution, revealing the coordination of the compound's triad of oxygen atoms with the two metal ions in the influenza A endonuclease active site.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo náměstí 542/2, Prague 6, 160 00, Czech Republic.
- First Faculty of Medicine, Charles University in Prague, Kateřinská 1660/32, Prague 2, 121 08, Czech Republic.
- Department of Organic Chemistry, Faculty of Science, Charles University in Prague, Hlavova 2030/8, Prague 2, 128 43, Czech Republic.
- Institute of Microbiology of the Czech Academy of Sciences, Vídeňská 1083, Prague 4, 140 00, Czech Republic.
ORCID profiles: Michal Kráľ, Tomáš Kotačka, Róbert Reiberger, Gabriela Panýrková, Kateřina Radilová, Zuzana Osifová, Jan Konvalinka, Pavel Majer, Milan Kožíšek, Aleš Machara
Funding
- European Union - Next Generation EU -
- National Institute of Virology and Bacteriology
- Academy of Sciences of the Czech Republic
- Akademie Věd České Republiky
Cite
APA
Kráľ, M., Kotačka, T., Reiberger, R., Panýrková, G., Radilová, K., Osifová, Z., Flieger, M., Konvalinka, J., Majer, P., Kožíšek, M., & Machara, A. (2025). 3’‐Dehydroxypurpurogallin‐4‐Carboxamides as Influenza A Endonuclease Inhibitors: Synthesis, Structure‐Activity Relationship Analysis, and Structural Characterization of Protein Complex. ChemMedChem. https://doi.org/10.1002/cmdc.202400577
Vancouver
Kráľ M, Kotačka T, Reiberger R, Panýrková G, Radilová K, Osifová Z, et al. 3’‐Dehydroxypurpurogallin‐4‐Carboxamides as Influenza A Endonuclease Inhibitors: Synthesis, Structure‐Activity Relationship Analysis, and Structural Characterization of Protein Complex. ChemMedChem. 2025. doi:10.1002/cmdc.202400577
BibTeX
@article{Kr2025,
author = {Kráľ, Michal and Kotačka, Tomáš and Reiberger, Róbert and Panýrková, Gabriela and Radilová, Kateřina and Osifová, Zuzana and Flieger, Miroslav and Konvalinka, Jan and Majer, Pavel and Kožíšek, Milan and Machara, Aleš},
title = {3’‐Dehydroxypurpurogallin‐4‐Carboxamides as Influenza A Endonuclease Inhibitors: Synthesis, Structure‐Activity Relationship Analysis, and Structural Characterization of Protein Complex},
journal = {ChemMedChem},
year = {2025},
doi = {10.1002/cmdc.202400577}
}
EUVIMED